Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 26 September 2024

This extraordinary CHMP meeting is organised to discuss emerging data with the sickle cell disease medicine Oxbryta (voxelotor).
EventHumanReferrals

Italian is available via eTranslation, the European Commission's machine translation service.

Translate to Italian | Important information about machine translation

Date

, -

Sede

Online
European Medicines Agency, Amsterdam, the Netherlands

The Committee for Medicinal Products for Human Use (CHMP) is responsible for preparing the European Medicines Agency's opinions on all questions concerning human medicines.

Agenda of the Extraordinary CHMP meeting 26 September 2024

Draft Reference Number: EMA/CHMP/447920/2024

English (EN) (206.34 KB - PDF)

Pubblicato per la prima volta:
Visualizza

Share this page